Press release Read more about Additional offtake secured - adding appx MEUR 45 - 60 in future company EBITDA and successful renegotiation of pricing structure of offtake agreement completed.
Press release Read more about Nykode Therapeutics Announces Collaboration with The GOG Foundation, Inc. to Conduct the VB-C-04 Trial in Advanced Cervical Cancer
Press release Read more about Galapagos presented encouraging initial safety and efficacy data at 2023 EBMT-EHA for point-of-care manufactured CAR-T candidate, GLPG5201, in rrCLL
Press release Read more about Argeo: Exercise of warrants and transactions by primary insiders and their close associates